Utah Medical Products (UTMD) Stock Price, News & Analysis

Company Overview

Utah Medical Products, Inc. (NASDAQ: UTMD) develops, manufactures and markets disposable medical devices used in hospital and clinical settings. The company focuses primarily on products for obstetrics, gynecology, neonatal care, electrosurgery and related surgical procedures.

Its product portfolio includes fetal monitoring electrodes and catheters, intrauterine pressure catheters, uterine manipulators, cervical dilators, neonatal respiratory products, electrosurgical instruments, grounding pads, biopsy devices and other specialized disposable instruments. These products are designed for use by physicians, nurses and other healthcare professionals.

Founded in 1978 and headquartered in Midvale, Utah, Utah Medical Products serves customers in the United States and international markets. The company sells its products through direct sales and distributors, with international operations and distribution supporting customers in regions including Europe and other global markets.

Key Stats

• Today's Range: $74.13 to $74.43
• 50-Day Range: $69.10 to $76.66
• 52-Week Range: $53.66 to $76.89
• Volume: 19,638 shs
• Average Volume: 31,442 shs
• Market Capitalization: $235.73 million
• P/E Ratio: 22.60
• Dividend Yield: 1.67%
• Price Target: N/A
• Consensus Rating: Hold

Utah Medical Products Stock Analysis - MarketRank™

Utah Medical Products scored higher than 19% of companies evaluated by MarketBeat, and ranked 805th out of 887 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

Utah Medical Products has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Utah Medical Products has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Utah Medical Products is 22.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.66.

Price to Earnings Ratio vs. Sector

The P/E ratio of Utah Medical Products is 22.60, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.69.

Price to Book Value per Share Ratio

Utah Medical Products has a P/B Ratio of 1.99. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.88% of the float of Utah Medical Products has been sold short.

Short Interest Ratio / Days to Cover

Utah Medical Products has a short interest ratio ("days to cover") of 4.53.

Change versus previous month

Short interest in Utah Medical Products has recently increased by 3.22%, indicating that investor sentiment is decreasing.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Utah Medical Products pays a meaningful dividend of 1.67%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Utah Medical Products has only been increasing its dividend for 3 years.

Dividend Coverage

The dividend payout ratio of Utah Medical Products is 37.80%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 1.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Utah Medical Products insiders have not sold or bought any company stock.

Percentage Held by Insiders

8.00% of the stock of Utah Medical Products is held by insiders.

Percentage Held by Institutions

69.60% of the stock of Utah Medical Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/23/2026
• Record date for 10/5 Dividend: 9/17/2026
• Ex-Dividend for 10/5 Dividend: 9/17/2026
• Today: 10/04/2026
• Dividend Payable: 10/05/2026
• Next Earnings (Estimated): 10/22/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Supplies
• Current Symbol: NASDAQ:UTMD
• CIK: 706698
• Web: www.utahmed.com
• Phone: (801) 566-1200
• Fax: 801-566-7305
• Employees: 152
• Year Founded: 1978

Profitability

• EPS (Trailing Twelve Months): $3.28
• Trailing P/E Ratio: 22.60
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $11.29 million
• Net Margins: 29.04%
• Pretax Margin: 35.68%
• Return on Equity: 8.74%
• Return on Assets: 8.50%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 48.62
• Quick Ratio: 44.27

Sales & Book Value

• Annual Sales: $38.52 million
• Price / Sales: 6.12
• Cash Flow: $4.46 per share
• Price / Cash Flow: 16.61
• Book Value: $37.23 per share
• Price / Book: 1.99

Miscellaneous

• Outstanding Shares: 3,180,000
• Free Float: 2,929,000
• Market Cap: $235.73 million
• Optionable: Not Optionable
• Beta: 0.38